← Back to Search

Group 3 for Healthy Subjects

N/A
Recruiting
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Normal (age-appropriate) binaural pure-tone hearing threshold (0.5-4k Hz; ≤25 dB HL for younger than 70 years, and ≤35 dB HL for older than 70 years)
Not taking any medications that affect the central nervous system
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within each session of the study that may last up to 2 hours
Awards & highlights

Study Summary

This trial aims to understand and improve stuttering, which can make it difficult for people to communicate and affect their quality of life. Participants will be asked to perform various tasks while their speech, muscle,

Who is the study for?
This trial is for monolingual, native American English speakers who stutter but don't have other developmental, psychological, neurological disorders. They must have normal hearing and not be on central nervous system medications. Adults can't have conditions that make brain stimulation or MRI unsafe.Check my eligibility
What is being tested?
The study tests how individuals who stutter predict and process auditory errors before speaking. It involves naming pictures, reading silently or aloud, listening to sounds while monitoring speech, muscle, and brain signals. Some may get brain stimulation during these tasks.See study design
What are the potential side effects?
Potential side effects are not explicitly listed in the provided information but could include discomfort from wearing monitoring equipment or mild reactions to brain stimulation like a headache or scalp sensations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My hearing is normal for my age.
Select...
I am not on any medications that affect my brain or nerves.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within each session of the study that may last up to 2 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and within each session of the study that may last up to 2 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in brain activity before and during speaking
change in speech when participants experience auditory errors

Trial Design

4Treatment groups
Experimental Treatment
Group I: Group 4Experimental Treatment1 Intervention
Group II: Group 3Experimental Treatment1 Intervention
Group III: Group 2Experimental Treatment1 Intervention
Group IV: Group 1Experimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
287 Previous Clinical Trials
108,951 Total Patients Enrolled
University of WashingtonOTHER
1,755 Previous Clinical Trials
1,841,873 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
331 Previous Clinical Trials
177,873 Total Patients Enrolled
~200 spots leftby Dec 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top